Christine Klinguer-Hamour

Title: Christine Klinguer-Hamour: Innovator in Antibody-Drug Conjugate Research

Introduction

Christine Klinguer-Hamour is a prominent inventor based in Groisy, France. She has made significant contributions to the field of biomedicine, particularly in the development of antibody-drug conjugates (ADCs). With a total of six patents to her name, her work has advanced the understanding and application of these complex molecules in cancer diagnosis and treatment.

Latest Patents

Among her latest patents is a universal method to capture and analyze ADCs for characterization of drug distribution and the drug-to-antibody ratio in biological samples. This invention provides a new approach for capturing and analyzing ADCs in biological samples, such as serum. Additionally, she has developed an anti-CXCR4 antibody for the detection and diagnosis of cancer. This novel, isolated antibody specifically recognizes monomeric and homodimeric CXCR4, while not interacting with heterodimeric CXCR4.

Career Highlights

Christine Klinguer-Hamour has established herself as a key figure in her field through her innovative research and patent contributions. Her work at Pierre Fabre Medicament has allowed her to collaborate with other experts and push the boundaries of current medical technologies.

Collaborations

She has worked alongside talented colleagues, including Alexandra Jouhanneaud and Véronique Grenier-Caussanel. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Christine Klinguer-Hamour's contributions to the field of antibody-drug conjugates exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts continue to impact cancer diagnosis and treatment positively.